ad image

Community

Guy Tiene
Guy Tiene

Business Director, Partner, Nice Insight

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.
145 Contributions1 / 8
Lessons Learned from the Ground Floor of Life Science Advising
M&A

Lessons Learned from the Ground Floor of Life Science Advising

Guy Tiene

Nice Insight

PAP-Q3-20-NI-005Sep 29, 2020
Addressing the Challenges and Opportunities Presented by Advanced Therapies
Drug Development

Addressing the Challenges and Opportunities Presented by Advanced Therapies

Guy Tiene

Nice Insight

PAO-M01-19-NI_CL-001Jan 15, 2019
French Pharma Company Ipsen Moves US Headquarters from New Jersey to Boston
Announcement

French Pharma Company Ipsen Moves US Headquarters from New Jersey to Boston

Guy Tiene

Nice Insight

PAO-M06-18-NI-013Jun 15, 2018
Pfizer Expands Investment in Biotech through Pfizer Ventures
Investment

Pfizer Expands Investment in Biotech through Pfizer Ventures

Guy Tiene

Nice Insight

PAO-M06-18-NI-010Jun 14, 2018
Loxo Oncology Reports Positive Results for Second Targeted Cancer Therapy

Loxo Oncology Reports Positive Results for Second Targeted Cancer Therapy

Guy Tiene

Nice Insight

PAO-M06-18-NI-001Jun 05, 2018
More Positive Phase 3 Results for Roche’s Tecentriq
Clinical Data

More Positive Phase 3 Results for Roche’s Tecentriq

Guy Tiene

Nice Insight

PAO-M05-18-NI-024May 31, 2018
Investing in Chinese Pharma Companies Proves Profitable
Investment

Investing in Chinese Pharma Companies Proves Profitable

Guy Tiene

Nice Insight

PR-M05-18-NI-023May 31, 2018
Challenges for Next-Generation Biological Therapeutics in Discovery and Development
Next-Generation Drug Development

Challenges for Next-Generation Biological Therapeutics in Discovery and Development

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-18-FA-001May 29, 2018
Thinking a Generation Ahead: Biologics-Based Therapy
Next-Generation Manufacturing

Thinking a Generation Ahead: Biologics-Based Therapy

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-18-FA-002May 29, 2018
Finishing Touches – The Future of Fill-Finish and Pharma Packaging
Next-Generation Packaging

Finishing Touches – The Future of Fill-Finish and Pharma Packaging

Guy Tiene; Cynthia A. Challener, Ph.D.; Emilie Branch

Nice Insight

PAP-Q2-18-FA-003May 29, 2018
TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date
Drug Discovery

TEVA Hopes to Launch New Migraine Drug Immediately After PDUFA Date

Guy Tiene

Nice Insight

PAO-M05-18-NI-020May 29, 2018
RNA-Modifying Proteins May Provide New Drug Targets
Drug Discovery

RNA-Modifying Proteins May Provide New Drug Targets

Guy Tiene

Nice Insight

PAO-M05-18-NI-018May 24, 2018
New Single-Pill HIV Treatment Approved in Europe
Treatment

New Single-Pill HIV Treatment Approved in Europe

Guy Tiene

Nice Insight

PAO-M05-18-NI-015May 22, 2018
Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended
Immunotherapy

Medigene, Bluebird Bio Collaboration on TCR Immunotherapy Extended

Guy Tiene

Nice Insight

PAO-M05-18-NI-010May 17, 2018
New WuXi STA Solid-Dose API Plant Gets Okay from US FDA
FDA

New WuXi STA Solid-Dose API Plant Gets Okay from US FDA

Guy Tiene

Nice Insight

PAO-M05-18-NI-004May 10, 2018
New Lung Cancer Treatment Awarded Priority Review by FDA
FDA

New Lung Cancer Treatment Awarded Priority Review by FDA

Guy Tiene

Nice Insight

PAO-M04-18-NI-013Apr 17, 2018
GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis
Acquisition

GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis

Guy Tiene

Nice Insight

PAO-M04-18-NI-008Apr 12, 2018
Sanofi’s Sotagliflozin Accepted for Review by EMA
Diabetes

Sanofi’s Sotagliflozin Accepted for Review by EMA

Guy Tiene

Nice Insight

PAO-M04-18-NI-006Apr 04, 2018
Merck Projected to Spend the Most on Licensing Deals in 2018
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

Guy Tiene

Nice Insight

PAO-M04-18-NI-003Apr 04, 2018
Shingrix Vaccine Available at CVS
Vaccine

Shingrix Vaccine Available at CVS

Guy Tiene

Nice Insight

PAO-M03-18-NI-018Mar 22, 2018
1 / 8